VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
XYL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
XYLXylem Inc.
$119.42$28.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksXYLFinancials

Xylem Inc. (XYL) Financials

17Y historyFree accessUpdated daily

Revenue growth has normalized to 2.7% as of 2026Q1, while gross margins remain resilient within a tight 37.0% to 38.9% range despite inflationary pressures.

XYL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Sales/Revenue9.09B9.04B8.56B7.36B5.52B5.2B4.88B5.25B5.21B4.71B3.77B3.65B3.92B3.84B3.79B3.8B3.2B2.85B
Revenue Growth %5.75%5.52%16.27%33.36%6.29%6.54%-7.11%0.81%10.62%24.82%3.23%-6.72%2.06%1.21%-0.32%18.77%12.39%-
Cost of Goods Sold5.58B5.56B5.35B4.65B3.44B3.22B3.05B3.2B3.18B2.86B2.31B2.25B2.4B2.34B2.29B2.34B1.99B1.81B
COGS % of Revenue-61.54%62.49%63.1%62.26%61.98%62.47%61.02%61.09%60.68%61.26%61.57%61.36%60.93%60.38%61.58%62.09%63.6%
Gross Profit3.51B3.48B3.21B2.72B2.08B1.98B1.83B2.05B2.03B1.85B1.46B1.4B1.51B1.5B1.5B1.46B1.21B1.04B
Gross Margin %38.61%38.46%37.51%36.9%37.74%38.02%37.53%38.98%38.91%39.32%38.74%38.43%38.64%39.07%39.62%38.42%37.91%36.4%
Gross Profit Growth %-8.19%18.22%30.37%5.52%7.92%-10.56%0.99%9.45%26.69%4.06%-7.2%0.93%-0.2%2.81%20.35%17.07%-
Operating Expenses2.27B2.25B2.2B2.06B1.46B1.39B1.46B1.56B1.37B1.29B1.05B955M1.05B1.14B1.06B1.07B826M761M
OpEx % of Revenue-24.93%25.73%28.04%26.48%26.76%30%29.72%26.35%27.51%27.95%26.14%26.81%29.61%27.93%28.03%25.8%26.71%
Selling, General & Admin1.94B1.92B1.91B1.76B1.37B1.18B1.14B1.16B1.16B1.09B914M854M920M990M914M877M737M667M
SG&A % of Revenue-21.28%22.32%23.86%24.76%22.69%23.44%22.06%22.3%23.14%24.24%23.38%23.49%25.8%24.11%23.06%23.02%23.41%
Research & Development226M226M230M232M206M204M187M191M189M180M110M95M104M104M106M100M74M63M
R&D % of Revenue-2.5%2.69%3.15%3.73%3.93%3.84%3.64%3.63%3.82%2.92%2.6%2.66%2.71%2.8%2.63%2.31%2.21%
Other Operating Expenses4M103M62M76M-111M7M133M211M22M25M30M6M26M42M39M89M15M31M
Operating Income1.24B1.22B1.01B652M622M585M367M486M654M552M406M449M463M363M486M395M403M276M
Operating Margin %13.6%13.54%11.78%8.85%11.26%11.26%7.53%9.26%12.56%11.73%10.77%12.29%11.82%9.46%12.82%10.39%12.59%9.69%
Operating Income Growth %-21.21%54.75%4.82%6.32%59.4%-24.49%-25.69%18.48%35.96%-9.58%-3.02%27.55%-25.31%23.04%-1.99%46.01%-
EBITDA1.8B1.8B1.57B1.09B858M830M618M743M915M786M557M582M605M513M628M532M495M346M
EBITDA Margin %19.85%19.9%18.35%14.77%15.54%15.98%12.67%14.16%17.57%16.7%14.77%15.93%15.45%13.37%16.57%13.99%15.46%12.14%
EBITDA Growth %12.53%14.45%44.39%26.81%3.37%34.3%-16.82%-18.8%16.41%41.11%-4.3%-3.8%17.93%-18.31%18.05%7.47%43.06%-
D&A (Non-Cash Add-back)569M575M562M436M236M245M251M257M261M234M151M133M142M150M142M137M92M70M
EBIT1.23B1.21B1.13B684M490M587M362M483M687M580M486M455M489M453M443M400M388M307M
Net Interest Income-25M-29M-16M-21M-34M-69M-70M-62M-78M-79M-68M-53M-52M-53M-51M-14M00
Interest Income0028M28M16M7M7M5M4M3M2M2M2M2M4M3M00
Interest Expense25M29M44M49M50M76M77M67M82M82M70M55M54M55M55M17M00
Other Income/Expense-28M-42M78M-17M-182M-74M-82M-70M-69M-86M-68M-46M-42M-65M-94M-12M-15M1M
Pretax Income1.21B1.18B1.09B635M440M511M285M416M585M466M340M403M421M298M388M383M388M277M
Pretax Margin %13.29%13.07%12.7%8.62%7.97%9.84%5.85%7.93%11.23%9.9%9.02%11.03%10.75%7.77%10.23%10.07%12.12%9.72%
Income Tax236M231M197M26M85M84M31M15M36M136M80M63M84M70M91M104M59M14M
Effective Tax Rate %19.54%19.56%18.12%4.09%19.32%16.44%10.88%3.61%6.15%29.18%23.53%15.63%19.95%23.49%23.45%27.15%15.21%5.05%
Net Income973M957M890M609M355M427M254M401M549M331M260M340M337M228M297M279M329M263M
Net Margin %10.7%10.59%10.39%8.27%6.43%8.22%5.21%7.64%10.54%7.03%6.89%9.31%8.61%5.94%7.83%7.34%10.27%9.23%
Net Income Growth %7.4%7.53%46.14%71.55%-16.86%68.11%-36.66%-26.96%65.86%27.31%-23.53%0.89%47.81%-23.23%6.45%-15.2%25.1%-
Net Income (Continuing)972M950M890M609M355M427M254M401M549M330M260M340M337M228M297M279M329M263M
Discontinued Operations000000000000000000
Minority Interest257M269M240M10M9M8M8M10M14M16M17M0000000
EPS (Diluted)4.003.923.652.791.962.351.402.213.031.831.451.871.831.221.591.501.781.42
EPS Growth %8.06%7.4%30.82%42.35%-16.6%67.86%-36.65%-27.06%65.57%26.21%-22.46%2.19%50%-23.27%6%-15.73%25.35%-
EPS (Basic)-3.933.672.811.972.371.412.233.051.841.451.881.841.231.601.511.781.42
Diluted Shares Outstanding243.36M244M243.5M218.18M180.98M181.53M181.1M181.2M181.1M180.9M180M181.7M184.2M186M186.2M185.3M184.6M184.6M
Basic Shares Outstanding242.76M243.4M242.6M216.98M180.22M180.25M180.12M179.99M179.8M179.6M179.1M180.9M183.1M185.2M185.8M185.1M184.6M184.6M
Dividend Payout Ratio-40.86%39.33%49.1%61.13%47.54%74.02%43.39%27.69%39.27%43.08%30%27.89%38.16%25.25%6.81%--

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetFortress
Cash FlowStable
Top Statement Risk

Municipal budget cycle sensitivity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Normalizing Post-Acquisition

According to the provided quarterly income statements, Xylem's revenue growth has decelerated from a peak of 40.4% in 2024Q1 to 2.7% by 2026Q1, reflecting a transition from inorganic expansion toward a more moderate, organic growth profile as the company integrates its recent large-scale acquisitions.

The sharp decline in year-over-year growth rates suggests that the initial tailwinds from the Evoqua integration are fading, leaving the company to rely on core municipal demand. Investors should monitor whether the current low-single-digit growth represents a sustainable baseline or a cyclical lull driven by the multi-year nature of infrastructure project funding.

Structural Gross Margin Stability Observed

As reported in financial statements, Xylem has maintained gross margins within a tight 37.0% to 38.9% range over the last ten quarters, indicating that the company possesses sufficient pricing power to offset inflationary pressures on raw materials like copper and steel within its engineered solutions.

This consistency suggests that the company's shift toward higher-margin digital and service-based offerings is effectively balancing the lower-margin hardware components in the Applied Water segment. However, the lack of significant margin expansion warrants further investigation into whether the company can successfully leverage its proprietary digital ecosystem to drive premium pricing.

Operating Leverage Remains Under Pressure

Based on Xylem's reported figures, operating margins have fluctuated between 10.0% and 14.7% over the past ten quarters, suggesting that the company has yet to achieve the significant operating leverage typically expected from a business scaling its high-margin software and recurring service revenue streams.

The persistent level of SG&A expenses relative to gross profit implies that integration costs and ongoing R&D investments are currently absorbing potential gains from operational efficiencies. This trend suggests that management's goal of transforming into a technology-led platform is still in a capital-intensive phase that limits immediate bottom-line scalability.

Earnings Volatility Masks Underlying Performance

Data from the income statement shows that net income has experienced significant quarterly swings, such as the jump to $335 million in 2025Q4, which appears largely disconnected from the more stable revenue trends and suggests the influence of non-operating items or tax-related adjustments.

The variance in net margins, which ranged from 7.5% to 14.5% over the observed period, indicates that GAAP earnings may not be the most reliable indicator of core operational health. Analysts should focus on adjusted metrics to strip away the noise created by acquisition-related amortization and the lumpy nature of large-scale municipal project recognition.

XYL — Frequently Asked Questions

Quick answers to the most common questions about buying XYL stock.

What was Xylem Inc.'s (XYL) revenue in 2025?

For fiscal year 2025, Xylem Inc. (XYL) reported total revenue of $9.04B. This represents a 217.1% increase compared to $2.85B in 2009.

Is Xylem Inc. (XYL) profitable?

Xylem Inc. (XYL) is profitable, generating $957.0M in net income for the fiscal year ending 2025 with a net profit margin of 10.6%.

What is Xylem Inc.'s operating profit margin?

Xylem Inc. (XYL) reported an operating income of $1.22B, resulting in an operating profit margin of 13.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Xylem Inc.'s gross profit and gross margin?

Xylem Inc. (XYL) generated $3.48B in gross profit for the year, representing a gross profit margin of 38.5%. This demonstrates the company's core pricing power and production efficiency.